NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
(E)-3-benzyl-1,2-dimethylguanidine
|
|
|
IUPAC Traditional name
|
|
Brand Name
|
|
Synonyms
|
Betanidine
|
Bethanidine sulfate
|
Betanidin
|
Bethanidine
|
|
|
CAS Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
Data Source
|
Data ID
|
Price
|
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
ALOGPS 2.1
H Acceptors
|
3
|
H Donor
|
2
|
LogD (pH = 5.5)
|
-1.1489159
|
LogD (pH = 7.4)
|
-1.1478196
|
Log P
|
1.266529
|
Molar Refractivity
|
54.5024 cm3
|
Polarizability
|
20.696774 Å3
|
Polar Surface Area
|
36.42 Å2
|
Rotatable Bonds
|
2
|
Lipinski's Rule of Five
|
true
|
Log P
|
1.41
|
LOG S
|
-2.05
|
Solubility (Water)
|
1.58e+00 g/l
|
PROPERTIES
PROPERTIES
Physical Property
Bioassay(PubChem)
Hydrophobicity(logP)
|
0.49
|
Show
data source
|
|
DETAILS
DETAILS
DrugBank
DrugBank -
DB00217
|
Item |
Information |
Drug Groups
|
approved |
Description
|
A guanidinium antihypertensive agent that acts by blocking adrenergic transmission. |
Indication |
For the treatment of hypertension. |
Pharmacology |
Bethanidine is a guanidinium antihypertensive agent that acts by blocking adrenergic transmission. The precise mode of action is not clear. Although bethanidine may produce adverse effects, they are beneficial in severe hypertension and produce fewer side effects than guanethidine. |
Affected Organisms |
• |
Humans and other mammals |
|
Absorption |
Absorbed rapidly in the gastrointestinal tract following oral administration. |
Half Life |
9 hours (range 7 to 11 hours) |
|
PATENTS
PATENTS
PubChem Patent
Google Patent